Properties of a microtubule-associated cofactor-independent protein kinase from pig brain

Phosphorylation of type III beta-tubulin PC12 cell neurites during NGF-induced process outgrowth

Nerve growth factor (NGF) produces both rapid and delayed cellular responses that are involved in neuronal differentiation. Neurite formation, a conspicuous delayed response, is accompanied by phosphorylation of beta-tubulin in PC12 cells. The present work provides further characterization of the phospho form of beta-tubulin in this neuronal model system with regard to isotype, cellular localization, and the circumstances that favor its formation. The results indicate that neuron-specific type III beta-tubulin (beta III-tubulin) is selectively affected during neurite formation. This phosphorylation occurs relatively late in the NGF signal transduction cascade and increases progressively with increasing duration of NGF treatment concomitant with more extensive neurite growth. The subcellular distribution of beta III-tubulin is not markedly different from that of total tubulin, but the phosphorylated protein is uniquely associated with microtubules that are calcium and cold labile. Although NGF is capable of inducing phosphorylation of beta III-tubulin, it is not necessarily sufficient. Based on experiments that employ either nonpermissive substrate conditions or microtubule-depolymerizing drugs, this phosphorylation requires neurite outgrowth. Direct measurements of the phospho form in neurites versus cell bodies by means of a microculture system indicate that phosphorylated beta III-tubulin is enriched in neurites. The enrichment of phospho-beta III-tubulin in calcium- and cold-labile polymer within neurites and its near absence in nonneurite bearing, NGF-treated cells suggests a role for this posttranslationally modified protein in the regulation of dynamic microtubules involved in neurite formation.

Contraction due to microtubule disruption is associated with increased phosphorylation of myosin regulatory light chain

Microtubules have been proposed to function as rigid struts which oppose cellular contraction. Consistent with this hypothesis, microtubule disruption strengthens the contractile force exerted by many cell types. We have investigated alternative explanation for the mechanical effects of microtubule disruption: that microtubules modulate the mechanochemical activity of myosin by influencing phosphorylation of the myosin regulatory light chain (LC20). We measured the force produced by a population of fibroblasts within a collagen lattice attached to an isometric force transducer. Treatment of cells with nocodazole, an inhibitor of microtubule polymerization, stimulated an isometric contraction that reached its peak level within 30 min and was typically 30-45% of the force increase following maximal stimulation with 30% fetal bovine serum. The contraction following nocodazole treatment was associated with a 2- to 4-fold increase in LC20 phosphorylation. The increases in both force and LC20 phosphorylation, after addition of nocodazole, could be blocked or reversed by stabilizing the microtubules with paclitaxel (former generic name, taxol). Increasing force and LC20 phosphorylation by pretreatment with fetal bovine serum decreased the subsequent additional contraction upon microtubule disruption, a finding that appears inconsistent with a load-shifting mechanism. Our results suggest that phosphorylation of LC20 is a common mechanism for the contractions stimulated both by microtubule poisons and receptor-mediated agonists. The modulation of myosin activity by alterations in microtubule assembly may coordinate the physiological functions of these cytoskeletal components.

Microtubule disruption stimulates system A transport in cultured vascular smooth muscle cells

This study has focused on the possible influence of microtubules for the regulation of Na(+)-dependent system A neutral amino acid transport in A10 cells, a cultured cell line derived from rat aortic vascular smooth muscle. When microtubules were disrupted by incubating cells for 5 h in serum-free medium containing colchicine, nocodazole, or vinblastine, there was a twofold increase in system A transport (Vmax change). The dose for the disruption of microtubules by colchicine was similar to the dose required for the stimulation of system A. The time course showed that system A stimulation did not occur until widespread disruption of microtubules was established. The stimulation was specific for system A; there were no changes in glucose transport and Na(+)-dependent transport of phosphate and glutamate. Serum refeeding of quiescent cells from 2 days of serum starvation led to stimulation of system A, glucose, and phosphate transport. However, only system A was activated when colchicine was added to the serum-free medium. Addition of colchicine during serum refeeding had no additive effect for the stimulation of system A. The stimulation by both colchicine and serum was blocked by cycloheximide and actinomycin D. These findings suggest that microtubule disruption may activate system A gene expression.